Published by
The Street
The Street
By GlobeNewswire RENO, Nev., Dec. 28, 2021 (GLOBE NEWSWIRE) — BioVie Inc., (BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of advanced liver disease and neurological and neurodegenerative disorders, today announced the participation of its management team in a panel and in one-on-one investor meetings at the LifeSci Partners 11th Annual Corporate Access Event, to be held virtually January 5-7, 2022. Details on the panel can be found below. LifeSci Partners 11th Annual Corporate Access Event Panel Topic: “Defining Yourself Whe…